ERIC D PAULEY
Allopathic & Osteopathic Physicians|Internal Medicine|Interventional Cardiology LEESBURG, VA NPI 1689019457
Browse related groups: Allopathic & Osteopathic Physicians|Internal Medicine|Interventional Cardiology VA Abbott Laboratories All categories
General Payments — all program years on this page
$3,538.12
- Category: General Payments
- Program years: PY2018–2024
- Record count: 143
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $1,180.44 across 49 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $1,180.44 | 49 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| Abbott Laboratories | $226.14 | 13 |
| E.R. Squibb & Sons, L.L.C. | $152.58 | 2 |
| Recor Medical Inc | $141.99 | 1 |
| Amgen Inc. | $88.04 | 4 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $77.69 | 5 |
| PFIZER INC. | $60.28 | 3 |
| Balt USA, LLC | $47.37 | 2 |
| Kiniksa Pharmaceuticals International, plc | $46.74 | 2 |
| Merck Sharp & Dohme Corporation | $46.39 | 2 |
| Novo Nordisk AS | $44.69 | 2 |
| Acerta Pharma LLC | $35.78 | 2 |
| BOSTON SCIENTIFIC CORPORATION | $35.28 | 2 |
| ABIOMED | $34.72 | 2 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $32.99 | 1 |
| Janssen Pharmaceuticals, Inc | $21.60 | 1 |
| Actelion Pharmaceuticals US, Inc. | $21.11 | 1 |
| Alnylam Pharmaceuticals Inc. | $19.11 | 1 |
| CVRx Inc. | $18.61 | 1 |
| ShockWave Medical, Inc | $15.74 | 1 |
| CHIESI USA, INC. | $13.59 | 1 |
By program year
Records — PY2024 (49)
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.